About
Zenflow, Inc. is a medical device company based in South San Francisco, California. It focuses on enhancing the quality of life for patients with urinary obstruction due to benign prostatic hyperplasia (BPH), a common condition in men. Founded by Stanford University Biodesign Fellows and leading urologists, Zenflow aims to provide a better treatment alternative to existing options. The company's main product is the Zenflow Spring System, a minimally invasive device designed to gently open the urethra using a nitinol coil. This system restores normal urinary function while preserving the natural anatomy of the prostate and urethra. It can be implanted through a simple office-based procedure, making it less painful and easier for urologists to perform. Currently, the Zenflow Spring System is an investigational device and is undergoing clinical trials. Zenflow emphasizes a patient-first approach and has raised approximately $79.4 million in funding to support its development efforts. The team includes experienced medtech engineers and regulatory experts, with a strong focus on delivering effective solutions for men suffering from BPH.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 2014
-
Annual Revenue $2000000
-
Total Funding $84768845
Location
395 Oyster Point Boulevard, South San Francisco, California, United States, 94080